BIOMARINE TECHNOLOGIES INC
SB-2/A, EX-27, 2000-10-11
PHARMACEUTICAL PREPARATIONS
Previous: BIOMARINE TECHNOLOGIES INC, SB-2/A, EX-23.1, 2000-10-11
Next: DINSMORE & SHOHL, SC 13D/A, 2000-10-11



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
Condensed Consolidated Financial Statements of BioMarine Technologies, Inc. and
is qualified in its entirety by reference to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          32,696
<SECURITIES>                                     1,262
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                32,696
<PP&E>                                          37,849
<DEPRECIATION>                                 124,821
<TOTAL-ASSETS>                                  72,832
<CURRENT-LIABILITIES>                          438,446
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        26,131
<OTHER-SE>                                   (391,747)
<TOTAL-LIABILITY-AND-EQUITY>                    72,832
<SALES>                                              0
<TOTAL-REVENUES>                                50,000
<CGS>                                                0
<TOTAL-COSTS>                                  253,744
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              17,307
<INCOME-PRETAX>                              (203,744)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (203,744)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (203,744)
<EPS-BASIC>                                     (0.09)
<EPS-DILUTED>                                   (0.09)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission